Papillary thyroid cancer historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]; Alison Leibowitz [3]

Overview

There is limited information about the historical perspective of papillary thyroid cancer.

Discovery

The most evident sign of thyroid pathology is goiter, which used to be referred to bronchocoele.
In 1656, Thomas Wharton named the gland the “thyroid,” referring to its shield-like shape.
In 1811, Bernard Courtois discovered iodine and in 1813, W. Prout used iodine to treat thyroid goiter.
In 1835, James Graves provided the primary description of exophthalmic goiter.
In 1833, Allan Burns and Gaspard Bayle distinguished thyroid cancer from goiter.^[1]
There is limited information about the historical perspective of papillary thyroid cancer.

In the 19th century, thyroid surgery became an increasingly standard practice with the help of anesthesia and antiseptics. ^[2]
In 1880, Ludwig Rehn preformed the first total thyroidectomy.
In 1885, J. Mikulicz-Radecki preformed the first subtotal thyroidectomy.
In 1934, Frederic and Irene Joliot-Curie discovered radioactive iodine isotope, which catalyzed diagnosis and treatment methods for thyroid diseases.
In 1909, Theodor Kocher was awarded the Nobel Prize for his research on the physiology and hormonal implications of the thyroid gland. ^[3]

Reference

↑ Template:Greene F, Komorowski A. Clinical Approach To Well-Differentited Thyroid Cancers. Delhi, India: Byworld Books; 2012.
↑ McCONAHEY W, HAY I, WOOLNER L, van HEERDEN J, TAYLOR W. Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome. Mayo Clinic Proceedings. 1986;61(12):978-996. doi:10.1016/s0025-6196(12)62641-x.
↑ Mazzaferri EL, Kloos RT (2001). “Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer”. J Clin Endocrinol Metab. 86 (4): 1447–63. doi:10.1210/jcem.86.4.7407. PMID 11297567.

Overview